Sign In

Brad Hirsch

Oncologist. Researcher. Entrepreneur. Investor.

Brad Hirsch is a healthcare executive and medical oncologist with extensive experience in clinical research, technology, and entrepreneurship.12 He currently serves as the Head of Product & Implementation at Verily, an Alphabet company focused on healthcare technology solutions.3

Career Highlights

Verily and SignalPath: Brad joined Verily in September 2021 when the company acquired SignalPath, a clinical trials technology solution he co-founded and led as CEO.12 He initially served as CEO of SignalPath within Verily before transitioning to his current role as Head of Product & Implementation in January 2023.1

Previous Roles: Prior to founding SignalPath, Brad held several notable positions:

  • Senior Medical Director at Flatiron Health
  • Assistant Professor at Duke University and Director of Informatics & Learning Labs at Duke Center for Learning Health Care
  • Medical Oncologist at Texas Oncology1

Education and Expertise

Brad's educational background combines medicine and business:

  • MD from UT Southwestern Medical Center
  • MBA from Duke University's Fuqua School of Business
  • BA from the University of Pennsylvania12

His expertise spans clinical oncology, health informatics, and clinical research technology. Brad has been a principal investigator on trials, which informs his approach to reimagining clinical research.2

Recent Developments

As of January 29, 2024, Brad announced that he would be moving on from his role at SignalPath/Verily.4 Subsequently, in September 2024, he co-founded Highlander Health with Amy Abernethy, another former Verily executive. This new venture aims to optimize clinical trials and improve data-driven clinical research.56

Highlights

Jan 29 · linkedin

After a decade, I am moving on from SignalPath/Verily at the end of the week. It was a true honor and privilege to collaborate with so many fantastic coworkers and partners over the years. The journey has been filled with great moments from our founding in 2013 over a beer at Tyler’s in Durham to our acquisition by Verily (Alphabet) in 2021 to the opportunity to oversee product across Verily over the past year. It is definitely a bittersweet moment as I am leaving my professional family. However, I am excited for the next chapter, continuing to partner with Amy Abernethy as I have been privileged to do for 15+ years. But first I am looking forward to going off the grid with my fantastic wife at the end of the week, camping on a beach somewhere in Mexico!

Oct 14 · linkedin

There are two critical leadership roles open on our product team at Verily in Digital Biomarkers and Participant Experience as well as an opening for a Senior Medical Director for Clinical Research. Please send great candidates our way.

Participant Experience - https://lnkd.in/gw2DWQbv

Digital Biomarkers - https://lnkd.in/garUVekb

Senior Medical Director for Research - https://lnkd.in/gJS9bX-N

Related Questions

What are Brad Hirsch's main responsibilities at Verily?
How did Brad Hirsch transition from being a medical oncologist to a healthcare technology executive?
What impact has Brad Hirsch had on clinical trials at Verily?
What inspired Brad Hirsch to co-found SignalPath?
How has Brad Hirsch's background in medicine influenced his approach to product development at Verily?
Brad Hirsch
Brad Hirsch, photo 1
Brad Hirsch, photo 2
Add to my network

Location

Dallas, Texas, United States